We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+19.85%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$1.79B
AUM Growth
+$298M
Cap. Flow
+$42.8M
Cap. Flow %
2.4%
Top 10 Hldgs %
26.42%
Holding
464
New
21
Increased
130
Reduced
91
Closed
43

Top Buys

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$33.9M
2
CELG
Celgene Corp
CELG
+$20.2M
3
BIIB icon
Biogen
BIIB
+$9.9M
4
GILD icon
Gilead Sciences
GILD
+$9.89M
5
BBWI icon
Bath & Body Works
BBWI
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 33.37%
2 Technology 20.44%
3 Consumer Discretionary 12.16%
4 Financials 8.69%
5 Communication Services 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENPH icon
101
Enphase Energy
ENPH
$4.63B
$4.31M 0.24%
475,000
EXEL icon
102
Exelixis
EXEL
$13.9B
$4.16M 0.23%
176,200
-7,500
-4% -$171K
IBM icon
103
IBM
IBM
$213B
$4.14M 0.23%
30,977
RUN icon
104
Sunrun
RUN
$2.26B
$4.06M 0.23%
284,500
-70,000
-20% -$964K
JPM icon
105
JPMorgan Chase
JPM
$916B
$4.05M 0.23%
40,115
+2,940
+8% +$303K
KYNB
106
Kyntra Bio
KYNB
$27.4M
$4M 0.22%
2,948
+1,612
+121% +$2.19M
PNC icon
107
PNC Financial Services
PNC
$99.1B
$3.95M 0.22%
32,347
+10,855
+51% +$1.34M
MS icon
108
Morgan Stanley
MS
$319B
$3.93M 0.22%
93,229
+33,170
+55% +$1.4M
EWJ icon
109
iShares MSCI Japan ETF
EWJ
$21.2B
$3.89M 0.22%
71,020
-5,300
-7% -$285K
ESGR
110
DELISTED
Enstar Group
ESGR
$3.83M 0.21%
22,000
-4,000
-15% -$694K
IONS icon
111
Ionis Pharmaceuticals
IONS
$8.93B
$3.83M 0.21%
+48,000
New +$3.1M
EPZM
112
DELISTED
Epizyme, Inc
EPZM
$3.79M 0.21%
308,200
+40,000
+15% +$447K
NKTR icon
113
Nektar Therapeutics
NKTR
$2.39B
$3.79M 0.21%
7,720
TERP
114
DELISTED
TerraForm Power, Inc
TERP
$3.72M 0.21%
270,390
EA icon
115
Electronic Arts
EA
$52.7B
$3.71M 0.21%
36,300
+14,300
+65% +$1.36M
FPRX
116
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$3.71M 0.21%
275,750
+95,000
+53% +$1.08M
NVDA icon
117
NVIDIA
NVDA
$4.6T
$3.7M 0.21%
834,000
-146,400
-15% -$568K
SGEN
118
DELISTED
Seagen Inc. Common Stock
SGEN
$3.64M 0.2%
50,750
KDNY
119
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$3.64M 0.2%
183,870
+98,870
+116% +$1.72M
LNC icon
120
Lincoln National
LNC
$7.92B
$3.64M 0.2%
62,170
+570
+0.9% +$33.8K
JNCE
121
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.52M 0.2%
568,687
+258,587
+83% +$1.25M
CMCSA icon
122
Comcast
CMCSA
$87.3B
$3.49M 0.2%
87,081
+6,365
+8% +$239K
ONC
123
BeOne Medicines Ltd
ONC
$33.9B
$3.49M 0.2%
27,600
MFC icon
124
Manulife Financial
MFC
$73B
$3.47M 0.19%
204,300
-4,700
-2% -$76.4K
CRM icon
125
Salesforce
CRM
$154B
$3.36M 0.19%
21,640
+4,560
+27% +$707K

Similar funds

Erste Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Erste Asset Management held 464 positions worth $1.79B, up 20% from $1.49B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Erste Asset Management's Q1 2019 filing shows 21 new, 130 increased, 91 reduced and 43 closed positions. Its largest new stake was Ionis Pharmaceuticals: 48,000 shares worth $3.83M. The largest sale was Bristol-Myers Squibb, an estimated $25.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Erste Asset Management's largest Q1 2019 buy was Ionis Pharmaceuticals: 48,000 shares worth $3.83M.
  • Erste Asset Management added most to Amarin Corp in Q1 2019, an estimated $33.9M increase.
  • Erste Asset Management's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $25.6M.
  • Erste Asset Management fully exited Charles Schwab in Q1 2019, selling an estimated $4.42M.
  • Erste Asset Management's ten largest holdings make up 26% of its $1.79B portfolio in Q1 2019.
  • Erste Asset Management opened 21 new positions and closed 43 in Q1 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $1.79B.

Based on Erste Asset Management's 13F filing for Q1 2019, filed 22 Nov 2024.